Article Information
History
- October 16, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hamid Salimi1,
- Matthew D. Cain1,
- Xiaoping Jiang1,
- Robyn A. Roth1,
- Wandy Beatty1,
- Chengqun Sun2,
- William B. Klimstra2,
- Jianghui Hou1 and
- Robyn S. Klein1,3,4,*
- 1Department of Medicine, Washington University School of Medicine, St. Louis, MO
- 2Department of Immunology and Center for Vaccine Research2, University of Pittsburgh, Pittsburgh, PA
- 3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO
- 4Department of Neuroscience, Washington University School of Medicine, St. Louis, MO
- ↵*Correspondence should be addressed to R.S.K. (rklein{at}wustl.edu). Robyn S. Klein, M.D., Ph.D., Washington University School of Medicine, Departments of Internal Medicine, Neurobiology, Pathology & Immunology, Campus Box 8051, 660 S. Euclid Ave, St. Louis, MO 63110, Phone: (314) 286-2140, Fax: (314) 362-9230, rklein{at}wustl.edu
Posted October 16, 2019.
Encephalitic alphaviruses exploit caveolae-mediated transcytosis at the blood-brain barrier for CNS entry
